Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women | 168 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women | 12 | 8 | 16 | 3 | 6 | 11 | 12 |
File Downloads
| Views | |
|---|---|
| hdl_138889.pdf | 36 |
| hdl_138889.pdf | 20 |
Top Country Views
| Views | |
|---|---|
| United States | 51 |
| Australia | 37 |
| Vietnam | 9 |
| Hong Kong SAR China | 8 |
| Singapore | 8 |
| China | 7 |
| Belgium | 5 |
| Ireland | 5 |
| Bulgaria | 2 |
| Sweden | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 11 |
| New York | 10 |
| Hanoi | 9 |
| Boardman | 6 |
| Central | 6 |
| Brussels | 5 |
| Clonee | 5 |
| Singapore | 5 |
| Brisbane | 3 |
| Sydney | 3 |